-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Amgen, Raises Price Target to $319

Benzinga·01/08/2026 16:43:07
语音播报
Truist Securities analyst Gregory Renza maintains Amgen (NASDAQ:AMGN) with a Hold and raises the price target from $318 to $319.